Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Intraindividual Comparison of EMO IOLs

NCT05822089
completednot_applicable

EDOF and Multifocal IOL Study

NCT05573529
completednot_applicable

IOP and Ocular Biometrics Changes After Phacoemulsification in Glaucoma Patients and Controls

NCT04334473
completednot_applicable

Surgically Induced Astigmatism of Temporal Versus Nasal Clear Corneal Phacoemulsification

NCT00521833

Clinical Trials (4)

Showing 4 of 4 trials
NCT05822089Not Applicable

Intraindividual Comparison of EMO IOLs

Recruiting
NCT05573529Not Applicable

EDOF and Multifocal IOL Study

Completed
NCT04334473Not Applicable

IOP and Ocular Biometrics Changes After Phacoemulsification in Glaucoma Patients and Controls

Completed
NCT00521833Not Applicable

Surgically Induced Astigmatism of Temporal Versus Nasal Clear Corneal Phacoemulsification

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4